Clinical trial Recruiting at 1 site Observational Ages 13 to 18

Understanding self-harm behavior in at-risk adolescents

Official title: Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents

Run by University of Ljubljana, Faculty of Medicine · NCT05765864 · Data updated 2026-11-12

This study is trying to understand the risks of self-harm in at-risk teens who have been hospitalized for suicide risk, to help create better treatment guidelines.

Quick facts

Study typeObservational
Ages13 Years to 18 Years
SexAll
Enrollment400 (estimated)
SponsorUniversity of Ljubljana, Faculty of Medicine
Academic / other
Locations2 sites (Ljubljana and 1 other locations)
StatusRecruiting
StartedMarch 23, 2023
Main results expectedOctober 2025
Study endsOctober 2025
Registry record updatedMarch 28, 2025
Trial IDNCT05765864 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adolescents aged 13-19 who exhibit self-harming behaviors without suicidal intent.

Probably not a fit

Patients with confirmed acute psychotic disorders, severe physical illnesses, or those who have a history of suicidality or self-injurious behavior in a first-degree relative may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify acute and long-term risks associated with self-harm behaviors in adolescents, particularly those hospitalized for suicide risk. It will involve approximately 200 at-risk adolescents and an equal number of healthy controls, assessing various demographic, clinical, and psychological factors through questionnaires and genetic analyses. The study will track self-harm incidents and evaluate changes in risk factors over time, ultimately developing guidelines for more effective treatment of these behaviors.

Why it matters

Potential benefit: If successful, this study could lead to improved identification and treatment strategies for adolescents at risk of self-harm.

How similar studies have gone: Other studies have shown success in identifying risk factors for self-harm in adolescents, but this specific approach is novel in its comprehensive methodology.

Who can join: the full rules

Show full inclusion / exclusion criteria
CLINICAL GROUP:

Inclusion Criteria:

* Suicidality
* Self-harming with no intention to die

Exclusion Criteria:

* Confirmed acute psychotic disorder
* Intellectual disability
* Severe physical illness (e.g. cardiovascular or renal disease)
* Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy)
* Acute poisoning (including with psychoactive substances)

CONTROL GROUP:

Inclusion Criteria:

\- Age 13-19

Exclusion criteria:

* Suicidality
* Self-harming with no intention to die
* Known mental disorder (e.g. depression, bipolar disorder, schizophrenia, intellectual disability)
* Severe physical illness (e.g. cardiovascular or renal disease)
* Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy)
* Acute poisoning (including with psychoactive substances)
* Mental disorder, history of suicidality or self-injurious behaviour in a first-degree relative (a parent or a sibling).

Where it's running

  • University Psychiatric Clinic Ljubljana
    Ljubljana, Slovenia
    Recruiting
  • Medical Faculty - University of Ljubljana
    Ljubljana, Slovenia
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.